Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Crispr Therapeutics AG (CRSP) vs. Competitors

11,100 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CRSPCrispr Therapeutics AG$39.10$3.78B-8.21-20.67%Moderate BuyUnlock the CRSP analyst price target with TipRanks PremiumCRSPUnlock the CRSP top-analyst price target with TipRanks Premium
NTLAIntellia Therapeutics$10.00$1.34B-2.8424.38%HoldUnlock the NTLA analyst price target with TipRanks PremiumCRSP vs NTLAUnlock the NTLA top-analyst price target with TipRanks Premium
BEAMBeam Therapeutics$20.90$2.17B-20.941.46%Strong BuyUnlock the BEAM analyst price target with TipRanks PremiumCRSP vs BEAMUnlock the BEAM top-analyst price target with TipRanks Premium
LEGNLegend Biotech$15.25$3.12B-1610.00-44.61%Moderate BuyUnlock the LEGN analyst price target with TipRanks PremiumCRSP vs LEGNUnlock the LEGN top-analyst price target with TipRanks Premium
KYMRKymera Therapeutics$115.31$10.19B-32.8978.42%Strong BuyUnlock the KYMR analyst price target with TipRanks PremiumCRSP vs KYMRUnlock the KYMR top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CRSPCrispr Therapeutics AG39.10-11.13-22.16%
NTLAIntellia Therapeutics10.001.7921.80%
BEAMBeam Therapeutics20.90-1.31-5.90%
LEGNLegend Biotech15.25-12.92-45.86%
KYMRKymera Therapeutics115.3149.2774.61%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts